Average rating
Cast your vote
You can rate an item by clicking the amount of stars they wish to award to this item.
When enough users have cast their vote on this item, the average rating will also be shown.
Star rating
Your vote was cast
Thank you for your feedback
Thank you for your feedback
Journal title
Antimicrobial agents and chemotherapyDate Published
2019-01-29Publication Volume
63Publication Issue
2
Metadata
Show full item recordAbstract
The activities of omadacycline, azithromycin, doxycycline, moxifloxacin, and levofloxacin were tested against 15 isolates of The minimum inhibitory concentration at which 90% of the isolates of were inhibited by omadacycline was 0.25 μg/ml (range, 0.03 to 0.5 μg/ml).Citation
Kohlhoff SA, Huerta N, Hammerschlag MR. In Vitro Activity of Omadacycline against Chlamydia pneumoniae. Antimicrob Agents Chemother. 2019 Jan 29;63(2):e01907-18. doi: 10.1128/AAC.01907-18. PMID: 30509942; PMCID: PMC6355552.DOI
10.1128/AAC.01907-18ae974a485f413a2113503eed53cd6c53
10.1128/AAC.01907-18
Scopus Count
Collections
The following license files are associated with this item:
- Creative Commons
Except where otherwise noted, this item's license is described as Copyright © 2019 American Society for Microbiology.
Related articles
- In vitro activity of AZD0914, a novel DNA gyrase inhibitor, against Chlamydia trachomatis and Chlamydia pneumoniae.
- Authors: Kohlhoff SA, Huband MD, Hammerschlag MR
- Issue date: 2014 Dec
- In vitro activities of azithromycin and doxycycline against 15 isolates of Chlamydia pneumoniae.
- Authors: Gnarpe J, Eriksson K, Gnarpe H
- Issue date: 1996 Aug
- In Vitro Activities of Omadacycline (PTK 0796) and Other Antimicrobial Agents against Human Mycoplasmas and Ureaplasmas.
- Authors: Waites KB, Crabb DM, Liu Y, Duffy LB
- Issue date: 2016 Dec
- In vitro activities of azithromycin, clarithromycin, and other antibiotics against Chlamydia pneumoniae.
- Authors: Kuo CC, Jackson LA, Lee A, Grayston JT
- Issue date: 1996 Nov
- In vitro activity of nemonoxacin, a novel nonfluorinated quinolone antibiotic, against Chlamydia trachomatis and Chlamydia pneumoniae.
- Authors: Chotikanatis K, Kohlhoff SA, Hammerschlag MR
- Issue date: 2014